REGENERON PHARMACEUTICALS, INC. — Form 4
Filed November 4, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 59/100
What the filing says
Director SING GEORGE L (REGN) sold 36K shares (~$20.4M) on the open market (59% of holdings). Large sale — ~59% of holdings.
Why this rating
Large sale — ~59% of holdings.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.